Funding

PhenX has been funded by the National Human Genome Research Institute (NHGRI) since 2007. Current PhenX funding is as a Biomedical Knowledgebase (U24HG012556) with co-funding from the National Heart, Lung, and Blood Institute (NHLBI), the National Institute of Neurological Disorders and Stroke (NINDS), and the National Institute on Minority Health and Health Disparities (NIMHD). In addition, prior funding for PhenX has been provided by the Office of the Director, the National Institute on Drug Abuse (NIDA), the National Institute of Mental Health (NIMH), the National Cancer Institute (NCI), and the Tobacco Regulatory Science Program (TRSP) of the National Institutes of Health (NIH).